
Laxmi Dental Share Price Target 2027: Rs 216 Base, Rs 263 Bull and the Risks to Watch
Laxmi Dental share price Rs 200.00 (18 November 2026). Base target Rs 216, bull Rs 263, downside risk Rs 165. PE 35.06. 52W range Rs 155.88 to Rs 314.95.
Updated: 18 Nov 2026 • 10:05 am
Posted by:

Quick Answer
The Laxmi Dental share price target for 2027 is Rs 216, about 8.0% above the current price of Rs 200.00. The bull case is Rs 263, and the downside risk level, which is not a target, is Rs 165. The base case assumes earnings per share grow 4.7% a year, the pace seen from FY24 to FY26, with the stock holding its PE of 35.06. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a Laxmi Dental target price for 2027 should start with where the stock sits today. At Rs 200.00 on 18 November 2026, it is 36.5% below its 52-week high of Rs 314.95 and 28.3% above its 52-week low of Rs 155.88. That range spans 102% from low to high, so the entry point matters as much as the Laxmi Dental price forecast itself.
This article builds the Laxmi Dental share price target from reported numbers only: three years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.
Click Here – Get Free Investment Predictions
Laxmi Dental Stock Analysis: Company Overview and Key Stats
Laxmi Dental (NSE: LAXMIDENTL) has a market capitalisation of Rs 1,136 crore. In FY26 it reported revenue of Rs 286.40 crore and net profit of Rs 26.43 crore. The table collects the figures the Laxmi Dental share price target is built on.
| Metric | Value |
|---|---|
| Company | Laxmi Dental |
| NSE Ticker | LAXMIDENTL |
| CMP (18 November 2026) | Rs 200.00 |
| 52-Week High | Rs 314.95 |
| 52-Week Low | Rs 155.88 |
| Market Cap | Rs 1,136 crore |
| PE Ratio (TTM) | 35.06 |
| Industry PE | 62.11 |
| Price to Book | 4.29 |
| Return on Equity | 13.70% |
| Debt to Equity | 0.06 |
| EPS (TTM) | Rs 5.89 |
| Dividend Yield | 0.00% |
| 12-Month Base Target | Rs 216 |
| Bull Case | Rs 263 |
| Downside Risk Level (not a target) | Rs 165 |
Why Is Laxmi Dental Share Price Target Set at Rs 216 for 2027?
The arithmetic is short. Trailing EPS of Rs 5.89 grown for one year gives a forward EPS estimate of Rs 6.17, and multiplying it by the unchanged PE of 35.06 gives the Rs 216 base-case Laxmi Dental stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Laxmi Dental Target Price: Three Years of Results
Laxmi Dental grew revenue from Rs 195.26 crore in FY24 to Rs 286.40 crore in FY26, a compound annual growth rate of 21.1%. Net profit grew faster, from Rs 17.94 crore to Rs 26.43 crore (21.4% a year), which shows margin gains did part of the work and not just higher sales.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY24 | 195.26 | 17.94 | 4.80 | 0.00 |
| FY25 | 242.44 | 25.38 | 6.05 | 0.00 |
| FY26 | 286.40 | 26.43 | 5.26 | 0.00 |
FY26 revenue growth was 18.1%, slower than the two-year average of 21.1%, and net profit moved up 4.1%. EPS rose from Rs 4.80 in FY24 to Rs 5.26 in FY26. The FY27 outlook for the Laxmi Dental price target depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Laxmi Dental converted 9.2% of FY26 revenue into net profit, against 10.5% in FY25, within a three-year range of 9.2% to 10.5%. EBITDA margin was 16.1% in FY26 versus 21.5% in FY25.
In the September 2026 quarter, revenue was Rs 81.69 crore, up 9.4% from the same quarter a year earlier, while net profit of Rs 9.51 crore was up 25.8%. EBITDA came in at Rs 17.43 crore, up 30.0% year on year. The next quarterly result is the first test of whether the earnings assumption behind the Laxmi Dental stock target holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.06, and shareholders' equity grew from Rs 44.57 crore in FY24 to Rs 244.11 crore in FY26. Operating cash flow in FY26 was negative at Rs 5.00 crore against capital expenditure of Rs 18.37 crore, leaving negative free cash flow of Rs 23.37 crore. In FY25 free cash flow was Rs 27.75 crore, so cash generation has not been steady year to year.
Valuation Check for the Laxmi Dental Stock Target: PE, Price to Book and ROE
At a PE of 35.06 against an industry PE of 62.11, Laxmi Dental trades at a discount to its industry. Price to book is 4.29 on a book value of Rs 48.13 per share, and return on equity is 13.70%. A PE of 35.06 equals an earnings yield of 2.9%, and the FY26 dividend of Rs 0.00 per share gives a yield of 0.00%.
Shareholding Pattern and Institutional Holding
Promoters held 41.75% of Laxmi Dental in September 2026, and promoter holding has stayed near 41.75% since September 2025. Foreign institutional investors (FII) held 6.58% and domestic institutions (DII) held 9.77%, which puts total institutional holding at 16.35%. FII holding fell from 32.39% in September 2025 to 6.58% in September 2026. Public shareholders own the remaining 41.91%. A meaningful institutional holding adds a layer of research coverage and trading depth.
Laxmi Dental Share Price Targets for the Short Term and 12 Months
Short Term Laxmi Dental Stock Target Levels: Technical Setup
At Rs 200.00 on 18 November 2026, Laxmi Dental trades above its 50-day simple moving average of Rs 192.74 and below its 200-day exponential moving average of Rs 219.89. The 14-day RSI reads 72.8, which is overbought territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 219.89 (200-day exponential moving average) and the nearest support is Rs 192.74 (50-day simple moving average). A sustained move above Rs 219.89 would improve the short-term setup, while a close below Rs 192.74 would shift attention to the next support.
12 Month Laxmi Dental Target Price for 2027
The 12-month target of Rs 216 means a move of 8.0% up from Rs 200.00 over the next 12 months. It would still leave the stock 31.4% below its 52-week high of Rs 314.95. Anyone checking the Laxmi Dental share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.
How EPS Growth and PE Multiple Change the Laxmi Dental Target Price
| EPS Growth | PE 28.05 | PE 35.06 | PE 40.32 |
|---|---|---|---|
| 0.0% (EPS Rs 5.89) | Rs 165 | Rs 207 | Rs 237 |
| 4.7% (EPS Rs 6.17) | Rs 173 | Rs 216 | Rs 249 |
| 10.7% (EPS Rs 6.52) | Rs 183 | Rs 229 | Rs 263 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Laxmi Dental price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Laxmi Dental Stock Target in 2027
Bull Case Rs 263
The bull case Laxmi Dental price target needs EPS growth of 10.7%, which lifts forward EPS to Rs 6.52, and a PE multiple that rises 15% to 40.32. That gives Rs 263, 31.5% above the current price and below the 52-week high of Rs 314.95.
Downside Risk Level Rs 165
The downside risk level is not a target. It assumes EPS stays flat at Rs 5.89 and the PE falls 20% to 28.05. That gives Rs 165, 17.5% below the current price and above the 52-week low of Rs 155.88.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 10.7% | 40.32 | Rs 263 | +31.5% |
| Base Case | 4.7% | 35.06 | Rs 216 | +8.0% |
| Downside Risk | 0.0% | 28.05 | Rs 165 | -17.5% |
Key Risks to the Laxmi Dental Target Price for 2027
Growth Slowdown Risk for the Laxmi Dental Price Target
Revenue in the September 2026 quarter was up 9.4% year on year, and FY26 revenue growth was 18.1%. If growth slows from here, the EPS estimate behind the Laxmi Dental stock target will need revising.
Liquidity and Size Risk
Laxmi Dental has a market capitalisation of Rs 1,136 crore. Institutional holding is 16.35%, and promoters hold 41.75%. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.
Valuation and Margin Risk
Net margin was 9.2% in FY26, so a small slip in costs moves profit noticeably. At a PE of 35.06 versus an industry PE of 62.11, a de-rating toward the downside-risk PE of 28.05 would cut the price even if earnings hold.
Market and Technical Risk
Technical indicators add short-term risk: the 14-day RSI is 72.8 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time.
How to Invest in Laxmi Dental
Start with the live price and volume. Any Laxmi Dental share price target is only as current as the data behind it, and the data here is as of 18 November 2026, so refresh the Rs 200.00 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Laxmi Dental's PE, ROE, debt and shareholding in one place.
Check Laxmi Dental fundamentals on the Univest Screener
Then compare the three Laxmi Dental target price scenarios with your own view. If you expect EPS growth below 4.7%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Laxmi Dental live price and get daily stock recommendations.
Conclusion
The Laxmi Dental share price target for 2027 is Rs 216 in the base case, with Rs 263 as the bull case. The support for that view is arithmetic you can check: EPS grew 4.7% a year over FY24 to FY26, and the stock trades at a PE of 35.06. The risks are equally concrete, including a net margin of just 9.2% that leaves profit sensitive to costs and a downside scenario that cuts the price 18% if earnings stall. Use these numbers as a framework for judging the Laxmi Dental price target, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Laxmi Dental Share Price Target 2027
What is the Laxmi Dental share price target for 2027?
Ans. The base-case Laxmi Dental share price target for 2027 is Rs 216, which is 8.0% above the price of Rs 200.00 on 18 November 2026. The bull case is Rs 263 and the downside risk level, which is not a target, is Rs 165. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.
What is the Laxmi Dental share price today?
Ans. As of 18 November 2026, before market open, Laxmi Dental (NSE: LAXMIDENTL) is quoted at Rs 200.00, which is its last closing price from the previous session. That is 36.5% below the 52-week high of Rs 314.95 and 28.3% above the 52-week low of Rs 155.88. The market capitalisation of Rs 1,136 crore places it among small-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.
Is Laxmi Dental a buy or sell at the current price?
Ans. The data points both ways. On the positive side, EPS has grown 4.7% a year over FY24 to FY26 and the base case implies 8.0% upside; on the cautious side, the net margin is a thin 9.2%, and the downside risk level of Rs 165 is 18% below the current price. Whether Laxmi Dental fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.
What are the bull case target and downside risk level for Laxmi Dental shares?
Ans. The bull case in the Laxmi Dental share price target for 2027 is Rs 263, which assumes 10.7% EPS growth and a PE of 40.32, a 15% re-rating from today's multiple. That is 31.5% above the current price and below the 52-week high of Rs 314.95. The downside risk level is Rs 165, which assumes flat EPS and a PE of 28.05, 20% lower than today. It sits 17.5% below the current price and above the 52-week low of Rs 155.88, and it marks a risk to watch, not a target.
What are the main risks to the Laxmi Dental price target?
Ans. Four risks matter most for the Laxmi Dental share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 1,136 crore, the stock can move sharply on small volumes, and exits can take longer than entries. A fall to the downside-risk PE of 28.05 would cut the price even if earnings hold.
What is the PE ratio of Laxmi Dental and how does it compare with the industry?
Ans. The PE ratio of Laxmi Dental is 35.06, against an industry PE of 62.11, which is a discount to the industry. Price to book is 4.29 and return on equity is 13.70%, and the PE equals an earnings yield of 2.9%. The base case holds the PE unchanged, so the Laxmi Dental share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.
Who owns Laxmi Dental, and what is the promoter holding?
Ans. Promoters held 41.75% of Laxmi Dental in September 2026. FII held 6.58%, DII held 9.77% and the public held 41.91%. Together the two institutional groups hold 16.35%. Shareholding is filed every quarter, so it is worth rechecking after each result.
What were Laxmi Dental's latest quarterly results?
Ans. In the September 2026 quarter, Laxmi Dental reported revenue of Rs 81.69 crore (up 9.4% year on year) and net profit of Rs 9.51 crore (up 25.8%). For comparison, FY26 full-year revenue growth was 18.1% and net profit moved up 4.1%. Each new quarter either supports or weakens the EPS growth of 4.7% assumed in the base case.
Recent Articles

Andhra Paper Analyst Review 2027: Back to Profit in Q2, Stock at 0.64 Times Book and a Pollution Penalty Under Appeal
18 November 2026

Amrutanjan Analyst Review 2027: Q2 Profit Up 24%, Hygiene Grows Fast and the Stock Sits Near Its Low
18 November 2026

Amines and Plasticizers Analyst Review 2027: Profit Up 35% in Q2, Thin Margins and Zero Institutional Holding
18 November 2026

Alok Industries Analyst Review 2027: Revenue Up 15%, Loss Widens to ₹208 Crore and Net Worth Stays Negative
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Andhra Paper Analyst Review 2027: Back to Profit in Q2, Stock at 0.64 Times Book and a Pollution Penalty Under Appeal
Amrutanjan Analyst Review 2027: Q2 Profit Up 24%, Hygiene Grows Fast and the Stock Sits Near Its Low
Amines and Plasticizers Analyst Review 2027: Profit Up 35% in Q2, Thin Margins and Zero Institutional Holding
Alok Industries Analyst Review 2027: Revenue Up 15%, Loss Widens to ₹208 Crore and Net Worth Stays Negative
Allied Digital Analyst Review 2027: Revenue Up 14%, Profit Down 18% and the Stock Below Book Value
Popular this week
Allcargo Logistics Analyst Review 2027: A Smaller, Domestic Company After the Split, With Profit Back at ₹18 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





